Bio Analytical Research Corporation   Report issue

For profit Phase 3
Founded: Ghent Belgium (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2003
NCT00209534
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bio Analytical Research Corporation

Active Ingredients

Drugs in Phase 3 Trials (2)

fospropofol (lusedra) (2 trials)

janssen SARS-CoV2 vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Polyps (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2